Malawi Cancer Consortium Regional Center of Research Excellence for NCDs

 

WHY MALAWI? 

Our consortium is well-positioned to catalyze a broad, coordinated cancer control effort in Malawi, and address key scientific questions related to cancer in sub-Saharan Africa. Read More 

OUR PRIORITIES 

We aim to develop sufficient internal capacity such that Malawi can become a leader of cancer care and research in low-resource settings, as it has long been for HIV care and treatment. Read More 

OUR PARTNERS 

Collaboration is an important component of what we do and our success is supported by a remarkable cancer research network of diverse and accomplished partner institutions. Read More 

Recent Outputs

  • Global Oncology

    June 2019 – This article highlights the important role of cancer care and research outside the United States, particularly in low- and middle-income countries, in furthering innovative solutions for cancer that can be applied worldwide.

  • Epidemiological and Histopathological Profile of Malignant Melanoma in Malawi

    April 2019 – Studies on malignant melanoma have largely focused on Caucasian populations with very limited data on the disease in black Africans. This retrospective study characterizes melanoma cases in Lilongwe, Malawi and demonstrates that malignant melanoma occurs in black … Continued

  • Outcomes and Prognostic Indices in DLBCL in Malawi

    December 2018- Outcomes for diffuse large B-cell lymphoma (DLBCL) in sub-Saharan Africa are poorly described. We report mature data from one of the first prospective SSA cohorts and propose a setting-appropriate prognostic model.

Recent News